LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 33.78 | 771.67 | 1425 | 3499 | 0.4072 | 0.3247 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 36.00 | 771.67 | 1439 | 3884 | 0.3704 | 0.3064 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 36.00 | 771.67 | 1445 | 3884 | 0.3720 | 0.3087 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 38.22 | 771.67 | 1429 | 4299 | 0.3324 | 0.2823 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 38.22 | 771.67 | 1464 | 4299 | 0.3405 | 0.2949 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 40.44 | 771.67 | 1464 | 4738 | 0.3090 | 0.2771 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 40.44 | 771.67 | 1496 | 4738 | 0.3157 | 0.2877 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 42.67 | 771.67 | 1476 | 5155 | 0.2863 | 0.2670 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 42.67 | 771.67 | 1504 | 5155 | 0.2917 | 0.2758 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 44.89 | 771.67 | 1463 | 5541 | 0.2640 | 0.2522 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 44.89 | 771.67 | 1500 | 5541 | 0.2707 | 0.2633 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 47.11 | 771.67 | 1468 | 5941 | 0.2471 | 0.2441 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 47.11 | 771.67 | 1524 | 5941 | 0.2565 | 0.2600 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 49.33 | 771.67 | 1487 | 6392 | 0.2326 | 0.2399 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 49.33 | 771.67 | 1538 | 6392 | 0.2406 | 0.2537 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 51.55 | 771.67 | 1486 | 6829 | 0.2176 | 0.2316 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 51.55 | 771.67 | 1571 | 6829 | 0.2300 | 0.2536 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 53.77 | 771.67 | 1475 | 7256 | 0.2033 | 0.2219 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 53.77 | 771.67 | 1574 | 7256 | 0.2169 | 0.2467 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 55.99 | 771.67 | 1504 | 7690 | 0.1956 | 0.2229 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 55.99 | 771.67 | 1573 | 7690 | 0.2046 | 0.2395 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 58.21 | 771.67 | 1505 | 8085 | 0.1861 | 0.2179 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 58.21 | 771.67 | 1577 | 8085 | 0.1950 | 0.2348 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 60.44 | 771.67 | 1480 | 8530 | 0.1735 | 0.2067 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 60.44 | 771.67 | 1633 | 8530 | 0.1914 | 0.2414 | MN20160304_L01 | N12 |